Tilray Inc (NASDAQ:TLRY - Get Free Report)'s share price shot up 3.8% during mid-day trading on Tuesday . The stock traded as high as $1.80 and last traded at $1.79. 6,988,291 shares were traded during mid-day trading, a decline of 76% from the average session volume of 29,137,781 shares. The stock had previously closed at $1.72.
Analysts Set New Price Targets
Several brokerages have weighed in on TLRY. Alliance Global Partners boosted their price objective on Tilray from $2.25 to $2.75 and gave the stock a "neutral" rating in a report on Friday, April 5th. CIBC cut their price objective on shares of Tilray from $2.25 to $2.00 and set a "neutral" rating on the stock in a report on Wednesday, April 10th. Finally, Canaccord Genuity Group reduced their price objective on shares of Tilray from $4.25 to $4.00 and set a "buy" rating on the stock in a research note on Wednesday, April 10th.
Check Out Our Latest Stock Report on TLRY
Tilray Price Performance
The company has a market capitalization of $1.42 billion, a price-to-earnings ratio of -4.18 and a beta of 2.36. The company has a 50-day moving average price of $1.95 and a 200-day moving average price of $1.95. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.18 and a current ratio of 1.92.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of the company. Hudson Bay Capital Management LP grew its holdings in shares of Tilray by 29.4% in the 3rd quarter. Hudson Bay Capital Management LP now owns 16,181,157 shares of the company's stock valued at $38,673,000 after buying an additional 3,681,157 shares during the period. Gotham Asset Management LLC increased its holdings in shares of Tilray by 1,038.7% in the third quarter. Gotham Asset Management LLC now owns 1,168,774 shares of the company's stock worth $2,793,000 after acquiring an additional 1,066,137 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Tilray during the third quarter worth about $2,023,000. SG Americas Securities LLC raised its position in shares of Tilray by 272.5% during the third quarter. SG Americas Securities LLC now owns 265,166 shares of the company's stock worth $634,000 after purchasing an additional 193,986 shares during the period. Finally, Mackenzie Financial Corp lifted its holdings in shares of Tilray by 482.8% during the 4th quarter. Mackenzie Financial Corp now owns 206,659 shares of the company's stock valued at $477,000 after purchasing an additional 171,200 shares in the last quarter. Institutional investors and hedge funds own 9.35% of the company's stock.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Further Reading
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
